Apyx Medical Shares Rise 6% as Body-Contouring Push Hits New Milestone
Apyx Medical shares rose 6.4% to $4.15 Thursday after highlighting its AYON body-contouring device and announcing a return to Miami Swim Week. The company reported Q1 revenue of $12.5 million, up from $9.4 million, and narrowed its net loss to $2.1 million. Apyx received expanded FDA clearance for AYON in May and faces competition from Solta Medical and MicroAire. The company warned of possible future losses and shareholder dilution.